-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Carisma Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
- Carisma Therapeutics Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$11.7M, a 44.3% increase year-over-year.
- Carisma Therapeutics Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$76M, a 0.05% increase year-over-year.
- Carisma Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$88.7M, a 58% decline from 2022.
- Carisma Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$56.2M, a 557% decline from 2021.
- Carisma Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$8.55M, a 59.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)